GC
AGN

Greenlight Capital’s Allergan plc AGN Stock Holding History

Greenlight Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-437,200
Closed -$117M – 51
2016
Q1 		$117M Buy
437,200
+27,200
+7% +$7.79M 1.99% 17
2015
Q4 		$128M Buy
+410,000
New +$122M 2.34% 14

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Greenlight Capital's AGN Position: Q2 2016 in Review

Greenlight Capital sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 437,200 shares — an estimated $117M sold.

Greenlight Capital first reported a position in AGN in Q4 2015 and held it in 2 quarters. The position peaked at $128M in Q4 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Greenlight Capital reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Greenlight Capital sold 437,200 Allergan plc shares in Q2 2016, an estimated $117M.
  • Greenlight Capital first reported a position in Allergan plc in Q4 2015 and held it in 2 quarters.
  • Greenlight Capital's Allergan plc position peaked at $128M in Q4 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Greenlight Capital's 13F filing for Q2 2016, filed 15 Aug 2016.